In NASH with liver fibrosis, resmetirom improved NASH resolution and reduced fibrosis at 1 y.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 38830210.
- Also identified by DOI 10.7326/ANNALS-24-00206-JC.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Harrison SA, Bedossa P, Guy CD, et al. MAESTRO-NASH Investigators. <b>A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis.</b> N Engl J Med. 2024;390:497-509. 38324483.
Medical subject headings
- Liver Cirrhosis
- Non-alcoholic Fatty Liver Disease